Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBER/CDER Reorganization: Product Transfer Set, Resources Under Review

Executive Summary

The CBER/CDER reorganization working group is finalizing a list of approved and investigational products whose reviews would be shifted from the Center for Biologics Evaluation & Research to the Center for Drug Evaluation & Research

You may also be interested in...



CBER/CDER Cultures Are Similar, Galson Says; Will Familiarity Breed Content?

"Cultural differences" will not be a significant obstacle in the consolidation of FDA's drug and biologic reviews, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, maintained during the Food & Drug Law Institute Annual Educational Conference in Washington, D.C., April 2

CBER/CDER Cultures Are Similar, Galson Says; Will Familiarity Breed Content?

"Cultural differences" will not be a significant obstacle in the consolidation of FDA's drug and biologic reviews, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, maintained during the Food & Drug Law Institute Annual Educational Conference in Washington, D.C., April 2

FDA Standard Drug Review Goals Could be Lengthened By 1-2 Months, IG Says

FDA should consider extending by one or two months its 10-month goal for standard drug reviews, the HHS Inspector General said in a 1report released March 25

Related Content

UsernamePublicRestriction

Register

PS040719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel